| Literature DB >> 24155241 |
Michelle R Longmire1, Mikako Ogawa, Peter L Choyke, Hisataka Kobayashi.
Abstract
Dendrimers are versatile macromolecules with tremendous potential as magnetic resonance imaging (MRI) contrast agents. Dendrimer-based agents provide distinct advantages over low-molecular-weight gadolinium chelates, including enhanced r1 relaxivity due to slow rotational dynamics, tunable pharmacokinetics that can be adapted for blood pool, liver, kidney, and lymphatic imaging, the ability to be a drug carrier, and flexibility for labeling due to their inherent multivalency. Clinical applications are increasingly being developed, particularly in lymphatic imaging. Herein we present a broad overview of dendrimer-based MRI contrast agents with attention to the unique chemistry and physical properties as well as emerging clinical applications.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24155241 PMCID: PMC6330103 DOI: 10.1002/wnan.1250
Source DB: PubMed Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol ISSN: 1939-0041